Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Ethyl 2-(methylamino)acetate, also known as Mepacrine, is a colorless liquid with a slight odor, belonging to the class of organic compounds known as N-substituted carboxylic acid esters. It is an ester derivative of a carboxylic acid where the carboxyl group is attached to an ethyl group. ethyl 2-(methylamino)acetate is commonly used in the synthesis of pharmaceutical agents for the treatment of various medical conditions and serves as an intermediate in organic synthesis and a solvent in chemical reactions. Ethyl 2-(methylamino)acetate is considered a potentially hazardous chemical, necessitating proper handling and storage.

13200-60-7

Post Buying Request

13200-60-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13200-60-7 Usage

Uses

Used in Pharmaceutical Synthesis:
Ethyl 2-(methylamino)acetate is used as a key intermediate in the synthesis of pharmaceutical agents for the treatment of various medical conditions. Its unique chemical structure allows it to be incorporated into the development of new drugs, enhancing their therapeutic properties and effectiveness.
Used in Organic Synthesis:
As an intermediate in organic synthesis, ethyl 2-(methylamino)acetate plays a crucial role in the production of various organic compounds. Its reactivity and versatility make it a valuable component in the synthesis of a wide range of chemical products, including pharmaceuticals, agrochemicals, and specialty chemicals.
Used in Chemical Reactions as a Solvent:
Ethyl 2-(methylamino)acetate is utilized as a solvent in chemical reactions due to its ability to dissolve a variety of substances. Its solubility properties and mild reactivity make it suitable for use in various chemical processes, facilitating the formation of desired products and improving reaction efficiency.
Used in Research and Development:
In the field of research and development, ethyl 2-(methylamino)acetate serves as a valuable compound for exploring new chemical reactions, synthesizing novel compounds, and understanding the fundamental principles of organic chemistry. Its unique properties and reactivity contribute to the advancement of scientific knowledge and the discovery of innovative applications.

Check Digit Verification of cas no

The CAS Registry Mumber 13200-60-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,2,0 and 0 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 13200-60:
(7*1)+(6*3)+(5*2)+(4*0)+(3*0)+(2*6)+(1*0)=47
47 % 10 = 7
So 13200-60-7 is a valid CAS Registry Number.

13200-60-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 2-(methylamino)acetate

1.2 Other means of identification

Product number -
Other names Glycine,N-methyl-,ethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13200-60-7 SDS

13200-60-7Synthetic route

ethyl bromoacetate
105-36-2

ethyl bromoacetate

methylamine
74-89-5

methylamine

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

Conditions
ConditionsYield
In acetonitrile at 0 - 20℃;85%
In diethyl ether; benzene
sarcosine
107-97-1

sarcosine

ethanol
64-17-5

ethanol

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

Conditions
ConditionsYield
With hydrogenchloride for 2h; Heating;80%
With thionyl chloride for 5h; Reflux;65%
With hydrogenchloride
ethanol
64-17-5

ethanol

Glyoxal
131543-46-9

Glyoxal

methylamine
74-89-5

methylamine

A

N1,N2-dimethylglycinamide
44565-47-1

N1,N2-dimethylglycinamide

B

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

Conditions
ConditionsYield
im Rohr; reagiert analog mit anderen Alkyl- und Dialkylaminen;
ethanol
64-17-5

ethanol

(methylamino)acetonitrile
5616-32-0

(methylamino)acetonitrile

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

Conditions
ConditionsYield
With hydrogenchloride
formaldehyd
50-00-0

formaldehyd

potassium cyanide
151-50-8

potassium cyanide

methylamine sulfate

methylamine sulfate

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

Conditions
ConditionsYield
With water unter Einleiten von Kohlendioxyd und Kochen des entstandenen Nitrils mit alkoh. Salzsaeure auf dem Wasserbad;
ethanol
64-17-5

ethanol

methylamine
74-89-5

methylamine

polyglyoxal

polyglyoxal

A

N1,N2-dimethylglycinamide
44565-47-1

N1,N2-dimethylglycinamide

B

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

sarcosine ethyl ester hydrochloride
52605-49-9

sarcosine ethyl ester hydrochloride

triethylamine
121-44-8

triethylamine

A

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

B

triethylamine hydrochloride
554-68-7

triethylamine hydrochloride

Conditions
ConditionsYield
In dichloromethane
tert-butoxycarbonyl-methyl-amino-acetic acid ethyl ester
145060-76-0

tert-butoxycarbonyl-methyl-amino-acetic acid ethyl ester

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

Conditions
ConditionsYield
With trifluoroacetic acid In dichloromethane at 0 - 20℃;
sarcosine ethyl ester hydrochloride
52605-49-9

sarcosine ethyl ester hydrochloride

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

Conditions
ConditionsYield
With water
In water
methylamine hydrochloride
593-51-1

methylamine hydrochloride

chloroacetic acid ethyl ester
105-39-5

chloroacetic acid ethyl ester

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

Conditions
ConditionsYield
Stage #1: methylamine hydrochloride With potassium carbonate In acetonitrile at 15℃; for 1.5h;
Stage #2: chloroacetic acid ethyl ester In acetonitrile at 20℃; for 10h;
With potassium carbonate In acetonitrile at 20℃; for 10h;
Stage #1: methylamine hydrochloride With triethylamine In acetonitrile at 15℃; for 1.5h;
Stage #2: chloroacetic acid ethyl ester In acetonitrile at 20℃; for 10h;
GlyOEt*HCl
459-73-4

GlyOEt*HCl

methyl trifluoromethanesulfonate
333-27-7

methyl trifluoromethanesulfonate

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

Conditions
ConditionsYield
With 1,1,1,3',3',3'-hexafluoro-propanol at 20℃; for 1h;
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

3-nitro-benzaldehyde
99-61-6

3-nitro-benzaldehyde

C12H16N2O4
892414-09-4

C12H16N2O4

Conditions
ConditionsYield
Stage #1: Sarcosine ethyl ester; 3-nitro-benzaldehyde With titanium(IV) isopropylate In 1,2-dichloro-ethane at 20℃; for 0.166667h;
Stage #2: With sodium tris(acetoxy)borohydride In 1,2-dichloro-ethane at 20℃; for 2h;
100%
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

tert-butoxycarbonyl-methyl-amino-acetic acid ethyl ester
145060-76-0

tert-butoxycarbonyl-methyl-amino-acetic acid ethyl ester

Conditions
ConditionsYield
With triethylamine In dichloromethane for 66h;100%
With sodium hydrogencarbonate In water at 20℃;89%
7-chloro-3-[(5-chloromethyl)-([1,2,4]oxadiazol-3-yl)]-1-(tetrahydropyran-4-yl)methyl-1H-indole
928150-02-1

7-chloro-3-[(5-chloromethyl)-([1,2,4]oxadiazol-3-yl)]-1-(tetrahydropyran-4-yl)methyl-1H-indole

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

C22H27ClN4O4
1292847-34-7

C22H27ClN4O4

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In acetonitrile at 60℃; for 18h;100%
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

benzenesulfenyl chloride
931-59-9

benzenesulfenyl chloride

(Methyl-phenylsulfanyl-amino)-acetic acid ethyl ester
180253-99-0

(Methyl-phenylsulfanyl-amino)-acetic acid ethyl ester

Conditions
ConditionsYield
With triethylamine In diethyl ether at 0℃; for 1h;99%
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

ethyl 3-oxo-3-(3-nitrophenyl)propanoate
52119-38-7

ethyl 3-oxo-3-(3-nitrophenyl)propanoate

1-methyl-3-(α-hydroxy-3'-nitrobenzylidene)pyrrolidine-2,4-dione

1-methyl-3-(α-hydroxy-3'-nitrobenzylidene)pyrrolidine-2,4-dione

Conditions
ConditionsYield
Stage #1: Sarcosine ethyl ester; ethyl 3-oxo-3-(3-nitrophenyl)propanoate In xylene at 125 - 130℃; for 20h;
Stage #2: With sodium methylate In methanol; xylene at 20℃; for 48h;
98.2%
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

O-methallylsalicylaldehyde
38002-87-8

O-methallylsalicylaldehyde

(2RS,3aSR,9bRS)-2-ethoxycarbonyl-1,2,3,3a,4,9b-hexahydro-1,3a-dimethyl[1]benzopyrano[4,3-b]pyrrole

(2RS,3aSR,9bRS)-2-ethoxycarbonyl-1,2,3,3a,4,9b-hexahydro-1,3a-dimethyl[1]benzopyrano[4,3-b]pyrrole

Conditions
ConditionsYield
In xylene at 130℃; for 0.5h; microwave irradiation;98%
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

ethyl (E)-4-(2-formylphenoxy)but-2-enoate
83611-34-1

ethyl (E)-4-(2-formylphenoxy)but-2-enoate

1-methyl-1,2,3,3a,4,9b-hexahydro-5-oxa-1-aza-cyclopenta[a]naphthalene-2,3-dicarboxylic acid diethyl ester

1-methyl-1,2,3,3a,4,9b-hexahydro-5-oxa-1-aza-cyclopenta[a]naphthalene-2,3-dicarboxylic acid diethyl ester

Conditions
ConditionsYield
at 130℃; for 0.0833333h; microwave irradiation;98%
3-chloro-N-(4-chloro-2-{[(4-chlorophenyl)amino]carbonyl}phenyl)-4-(chloromethyl)-2-thiophenecarboxamide
229342-64-7

3-chloro-N-(4-chloro-2-{[(4-chlorophenyl)amino]carbonyl}phenyl)-4-(chloromethyl)-2-thiophenecarboxamide

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

C24H22Cl3N3O4S

C24H22Cl3N3O4S

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 0 - 20℃;98%
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

3,4-dichlorophenyl isocyanate
34893-92-0

3,4-dichlorophenyl isocyanate

3-(3,5-dichlorophenyl)-1-methyl-2,4-imidazolidinedione
27387-90-2

3-(3,5-dichlorophenyl)-1-methyl-2,4-imidazolidinedione

Conditions
ConditionsYield
With sodium hydroxide In tetrahydrofuran; water Inert atmosphere;96%
With sodium hydroxide In tetrahydrofuran; water96%
1,3,5-trichloro-2,4,6-triazine
108-77-0

1,3,5-trichloro-2,4,6-triazine

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

ethyl N-(4,6-dichloro-1,3,5-triazin-2-yl)-N-methylglycinate

ethyl N-(4,6-dichloro-1,3,5-triazin-2-yl)-N-methylglycinate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In acetone at 0℃; for 2h;94%
In tetrahydrofuran; ethyl acetate at -2℃; for 0.25h;
In tetrahydrofuran; ethyl acetate at -2℃;
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

1-{2-[(1S,4S)-5-(tert-butoxycarbonyl)-2,5-diazabicyclo[2.2.1]hept-2-yl]pyridin-4-yl}-3-(pyrazin-2-ylamino)-1H-indazole-6-carboxylic acid
1394067-24-3

1-{2-[(1S,4S)-5-(tert-butoxycarbonyl)-2,5-diazabicyclo[2.2.1]hept-2-yl]pyridin-4-yl}-3-(pyrazin-2-ylamino)-1H-indazole-6-carboxylic acid

ethyl N-{[1-{2-[(1S,4S)-2,5-diazabicyclo[2.2.1]hept-2-yl]pyridin-4-yl}-3-(pyrazin-2-ylamino)-1H-indazol-6-yl]carbonyl}-N-methylglycinate

ethyl N-{[1-{2-[(1S,4S)-2,5-diazabicyclo[2.2.1]hept-2-yl]pyridin-4-yl}-3-(pyrazin-2-ylamino)-1H-indazol-6-yl]carbonyl}-N-methylglycinate

Conditions
ConditionsYield
Stage #1: 1-{2-[(1S,4S)-5-(tert-butoxycarbonyl)-2,5-diazabicyclo[2.2.1]hept-2-yl]pyridin-4-yl}-3-(pyrazin-2-ylamino)-1H-indazole-6-carboxylic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 3h;
Stage #2: Sarcosine ethyl ester In N,N-dimethyl-formamide at 20℃;
94%
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

5-nitro-2-(prop-2-en-1-yloxy)benzaldehyde
96601-09-1

5-nitro-2-(prop-2-en-1-yloxy)benzaldehyde

ethyl (2RS,3aSR,9bRS)-1-methyl-8-nitro-1,2,3,3a,4,9b-hexahydrochromeno[4,3-b]pyrrole-2-carboxylate

ethyl (2RS,3aSR,9bRS)-1-methyl-8-nitro-1,2,3,3a,4,9b-hexahydrochromeno[4,3-b]pyrrole-2-carboxylate

Conditions
ConditionsYield
In neat (no solvent, solid phase) for 0.166667h; Microwave irradiation; Green chemistry;94%
formaldehyd
50-00-0

formaldehyd

N-p-tolylphenylmaleimide
1631-28-3

N-p-tolylphenylmaleimide

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

(3aS,6aR)-2-Methyl-4,6-dioxo-5-p-tolyl-octahydro-pyrrolo[3,4-c]pyrrole-1-carboxylic acid ethyl ester
106369-04-4, 106402-32-8

(3aS,6aR)-2-Methyl-4,6-dioxo-5-p-tolyl-octahydro-pyrrolo[3,4-c]pyrrole-1-carboxylic acid ethyl ester

Conditions
ConditionsYield
In toluene for 1h; Heating; Dean-Stark trap;93%
2-(allyloxy)benzaldehyde
28752-82-1

2-(allyloxy)benzaldehyde

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

(3aR,9bR)-1-Methyl-1,2,3,3a,4,9b-hexahydro-chromeno[4,3-b]pyrrole-2-carboxylic acid ethyl ester

(3aR,9bR)-1-Methyl-1,2,3,3a,4,9b-hexahydro-chromeno[4,3-b]pyrrole-2-carboxylic acid ethyl ester

ethyl (2RS,3aSR,9bRS)-1-methyl-1,2,3,3a,4,9b-hexahydrochromeno[4,3-b]pyrrole-2-carboxylate

ethyl (2RS,3aSR,9bRS)-1-methyl-1,2,3,3a,4,9b-hexahydrochromeno[4,3-b]pyrrole-2-carboxylate

Conditions
ConditionsYield
at 130℃; for 0.25h; microwave irradiation;A n/a
B 93%
2-[(E)-(3-phenyl-2-propenyl)oxy]benzaldehyde
28809-06-5

2-[(E)-(3-phenyl-2-propenyl)oxy]benzaldehyde

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

(3aRS,9bRS)-2-ethoxycarbonyl-1,2,3,3a,4,9b-hexahydro-1-methyl-3-phenyl[1]benzopyrano[4,3-b]pyrrole

(3aRS,9bRS)-2-ethoxycarbonyl-1,2,3,3a,4,9b-hexahydro-1-methyl-3-phenyl[1]benzopyrano[4,3-b]pyrrole

(2RS,3RS,3aSR,9bRS)-2-ethoxycarbonyl-1,2,3,3a,4,9b-hexahydro-1-methyl-3-phenyl[1]benzopyrano[4,3-b]pyrrole

(2RS,3RS,3aSR,9bRS)-2-ethoxycarbonyl-1,2,3,3a,4,9b-hexahydro-1-methyl-3-phenyl[1]benzopyrano[4,3-b]pyrrole

Conditions
ConditionsYield
In toluene for 4h; Heating;A n/a
B 93%
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

2-[(2-oxo-2H-chromen-4-yl)oxy]acetic acid
462094-45-7

2-[(2-oxo-2H-chromen-4-yl)oxy]acetic acid

ethyl 2-(N-methyl-2-(2-oxo-2H-chromen-4-yloxy)acetamido)acetate

ethyl 2-(N-methyl-2-(2-oxo-2H-chromen-4-yloxy)acetamido)acetate

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 0 - 25℃; for 8h;92.7%
(2S)-2-[(tert-Butoxycarbonyl)amino]-3-{[(2-nitrophenyl)sulfonyl]amino}propionic Acid

(2S)-2-[(tert-Butoxycarbonyl)amino]-3-{[(2-nitrophenyl)sulfonyl]amino}propionic Acid

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride
25952-53-8

1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride

{[(S)-2-tert-Butoxycarbonylamino-3-(2-nitro-benzenesulfonylamino)-propionyl]-methyl-amino}-acetic acid ethyl ester

{[(S)-2-tert-Butoxycarbonylamino-3-(2-nitro-benzenesulfonylamino)-propionyl]-methyl-amino}-acetic acid ethyl ester

Conditions
ConditionsYield
With benzotriazol-1-ol In chloroform; water; ethyl acetate; N,N-dimethyl-formamide91%
(2S)-2-[(tert-Butoxycarbonyl)amino]-3-{[(2-nitrophenyl)sulfonyl]amino}propionic Acid

(2S)-2-[(tert-Butoxycarbonyl)amino]-3-{[(2-nitrophenyl)sulfonyl]amino}propionic Acid

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

{[(S)-2-tert-butoxycarbonylamino-3-(2-nitrobenzenesulfonylamino)propionyl]methylamino}acetic acid ethyl ester
1276121-84-6

{[(S)-2-tert-butoxycarbonylamino-3-(2-nitrobenzenesulfonylamino)propionyl]methylamino}acetic acid ethyl ester

Conditions
ConditionsYield
Stage #1: (2S)-2-[(tert-Butoxycarbonyl)amino]-3-{[(2-nitrophenyl)sulfonyl]amino}propionic Acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at -10℃; for 0.5h;
Stage #2: Sarcosine ethyl ester In chloroform; N,N-dimethyl-formamide at -10 - 20℃;
91%
Stage #1: (2S)-2-[(tert-Butoxycarbonyl)amino]-3-{[(2-nitrophenyl)sulfonyl]amino}propionic Acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at -10℃; for 0.5h;
Stage #2: Sarcosine ethyl ester In chloroform; N,N-dimethyl-formamide at -10 - 20℃; for 1h;
91%
Stage #1: (2S)-2-[(tert-Butoxycarbonyl)amino]-3-{[(2-nitrophenyl)sulfonyl]amino}propionic Acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at -10℃; for 0.5h;
Stage #2: Sarcosine ethyl ester In chloroform; N,N-dimethyl-formamide at 20℃; for 1h;
91%
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

C10H19BrO2

C10H19BrO2

C15H29NO4

C15H29NO4

Conditions
ConditionsYield
With potassium carbonate In acetone at 140℃; for 14h; Microwave irradiation;91%
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

2-Benzyloxycarbonylamino-2-methyl-propionic acid 2-thioxo-2H-pyridin-1-yl ester
180253-97-8

2-Benzyloxycarbonylamino-2-methyl-propionic acid 2-thioxo-2H-pyridin-1-yl ester

[N-[N'-(2-benzyloxycarbonyl)amino-2-methylpropionyl]-N-methylamino]acetic acid ethyl ester
180254-00-6

[N-[N'-(2-benzyloxycarbonyl)amino-2-methylpropionyl]-N-methylamino]acetic acid ethyl ester

Conditions
ConditionsYield
With triethylamine In dichloromethane for 12h; Ambient temperature;90%
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

5-chloro-2-prop-2-enyloxybenzaldehyde
152842-93-8

5-chloro-2-prop-2-enyloxybenzaldehyde

8-chloro-1-methyl-1,2,3,3a,4,9b-hexahydro-5-oxa-1-aza-cyclopenta[a]naphthalene-2-carboxylic acid ethyl ester

8-chloro-1-methyl-1,2,3,3a,4,9b-hexahydro-5-oxa-1-aza-cyclopenta[a]naphthalene-2-carboxylic acid ethyl ester

8-chloro-1-methyl-1,2,3,3a,4,9b-hexahydro-5-oxa-1-aza-cyclopenta[a]naphthalene-2-carboxylic acid ethyl ester

8-chloro-1-methyl-1,2,3,3a,4,9b-hexahydro-5-oxa-1-aza-cyclopenta[a]naphthalene-2-carboxylic acid ethyl ester

Conditions
ConditionsYield
In toluene for 4h; Heating;A n/a
B 90%
polymer, [poly(ethylene glycol)-O-CO]2LysOSu, M = 20 kDa

polymer, [poly(ethylene glycol)-O-CO]2LysOSu, M = 20 kDa

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

polymer, [poly(ethylene glycol)-O-CO]2Lys-Sar-OEt, M = 20 kDa

polymer, [poly(ethylene glycol)-O-CO]2Lys-Sar-OEt, M = 20 kDa

Conditions
ConditionsYield
With triethylamine In chloroform at 20℃; for 12h; pH=8;90%
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

C5H5Br2N3*BrH
1559069-47-4

C5H5Br2N3*BrH

C10H15BrN4O2

C10H15BrN4O2

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 120℃; for 0.333333h;90%
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

3,4-dimethoxy-2-allylbenzaldehyde
92345-90-9

3,4-dimethoxy-2-allylbenzaldehyde

(2R,3aS,8bR)-5,6-Dimethoxy-1-methyl-1,2,3,3a,4,8b-hexahydro-indeno[1,2-b]pyrrole-2-carboxylic acid ethyl ester
92345-91-0

(2R,3aS,8bR)-5,6-Dimethoxy-1-methyl-1,2,3,3a,4,8b-hexahydro-indeno[1,2-b]pyrrole-2-carboxylic acid ethyl ester

Conditions
ConditionsYield
In toluene Heating;89%
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

benzoyl azide
582-61-6

benzoyl azide

1-methyl-3-phenyl-2,4-imidazolidinedione
2221-12-7

1-methyl-3-phenyl-2,4-imidazolidinedione

Conditions
ConditionsYield
With potassium carbonate at 100℃; for 8h;89%
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

methyl 2-(bromomethyl)-4,5-dimethoxybenzoate
63005-36-7

methyl 2-(bromomethyl)-4,5-dimethoxybenzoate

N-(2-carboethoxy-4,5-dimethoxybenzyl)sarcosine methyl ester
112434-97-6

N-(2-carboethoxy-4,5-dimethoxybenzyl)sarcosine methyl ester

Conditions
ConditionsYield
With sodium carbonate In toluene at 85℃; for 3.5h;87%
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

benzaldehyde
100-52-7

benzaldehyde

dimethylfumarate
624-49-7

dimethylfumarate

A

1-Methyl-5-phenyl-pyrrolidine-2,3,4-tricarboxylic acid 2-ethyl ester 3,4-dimethyl ester

1-Methyl-5-phenyl-pyrrolidine-2,3,4-tricarboxylic acid 2-ethyl ester 3,4-dimethyl ester

(2R,3R,4R,5R)-1-Methyl-5-phenyl-pyrrolidine-2,3,4-tricarboxylic acid 2-ethyl ester 3,4-dimethyl ester

(2R,3R,4R,5R)-1-Methyl-5-phenyl-pyrrolidine-2,3,4-tricarboxylic acid 2-ethyl ester 3,4-dimethyl ester

Conditions
ConditionsYield
In toluene for 1h; Heating; Yield given;A n/a
B 87%
In toluene for 1h; Heating; Yields of byproduct given;A n/a
B 87%
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

1,3-bis(tert-butoxycarbonyl)-2-methyl-2-thiopseudourea
107819-90-9

1,3-bis(tert-butoxycarbonyl)-2-methyl-2-thiopseudourea

N1,N2-bis(tert-butoxycarbonyl)-N3-methylguanidino-N3-acetic acid ethyl ester

N1,N2-bis(tert-butoxycarbonyl)-N3-methylguanidino-N3-acetic acid ethyl ester

Conditions
ConditionsYield
With triethylamine; mercury dichloride In N,N-dimethyl-formamide at 20℃; for 4h;87%
Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

ethyl m-toluoylacetate
33166-79-9

ethyl m-toluoylacetate

1-methyl-3-(α-hydroxy-3'-methylbenzylidene)pyrrolidine-2,4-dione

1-methyl-3-(α-hydroxy-3'-methylbenzylidene)pyrrolidine-2,4-dione

Conditions
ConditionsYield
Stage #1: Sarcosine ethyl ester; ethyl m-toluoylacetate In xylene at 125 - 130℃; for 20h;
Stage #2: With sodium methylate In methanol; xylene at 20℃; for 48h;
86.5%
5-((9H-carbazol-4yl)oxy)pentanoic acid

5-((9H-carbazol-4yl)oxy)pentanoic acid

Sarcosine ethyl ester
13200-60-7

Sarcosine ethyl ester

ethyl2-(5-((9H-carbazol-4yl)oxy)-N-methylpentanamido)acetate

ethyl2-(5-((9H-carbazol-4yl)oxy)-N-methylpentanamido)acetate

Conditions
ConditionsYield
With benzotriazol-1-ol; 1,2-dichloro-ethane; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 0 - 25℃; for 12h;86.2%

13200-60-7Relevant articles and documents

N, N -Bis-(dimethylfluorosilylmethyl)amides of N -organosulfonylproline and sarcosine: Synthesis, structure, stereodynamic behaviour and in silico studies

Nikolin, Alexey A.,Kramarova, Eugenia P.,Shipov, Alexander G.,Baukov, Yuri I.,Negrebetsky, Vadim V.,Arkhipov, Dmitry E.,Korlyukov, Alexander A.,Lagunin, Alexey A.,Bylikin, Sergey Yu.,Bassindale, Alan R.,Taylor, Peter G.

, p. 75315 - 75327 (2016)

(O→Si)-Chelate difluorides R3R2NCH(R1)C(O)N(CH2SiMe2F)2 (9a-c, R1R2 = (CH2)3, R3 = Ms (a), Ts (b); R1 = H, R2 = Me, R3 = Ms (c)), containing one penta- and one tetracoordinate silicon atoms were synthesized by silylmethylation of amides R3R2NCH(R1)C(O)NH2, subsequent hydrolysis of unstable intermediates R3R2NCH(R1)C(O)N(CH2SiMe2Cl)2 (7a-c) into 4-acyl-2,6-disilamorpholines R3R2NCH(R1)C(O)N(CH2SiMe2O)2 (8a-c) and the reaction of the latter compounds with BF3·Et2O. The structures of disilamorpholines 8a,c and difluoride 9a were confirmed by an X-ray diffraction study. According to the IR and NMR data, the O→Si coordination in solutions of these compounds was weaker than that in the solid state due to effective solvation of the Si-F bond. A permutational isomerisation involving an exchange of equatorial Me groups at the pentacoordinate Si atom in complexes 9a-c was detected, and its activational parameters were determined by 1H DNMR. In silico estimation of possible pharmacological effects and acute rat toxicity by PASS Online and GUSAR Online services showed a potential for their further pharmacological study.

Microwave-assisted synthesis of substituted hexahydropyrrolo[3,2-c] quinolines

Neuschl, Michal,Bogdal, Darek,Potacek, Milan

, p. 49 - 59 (2007)

New compounds with the ethyl hexahydro-1H-pyrrolo[3,2-c]quinoline-2- carboxylate skeleton were prepared by microwave-assisted intramolecular 1,3-dipolar cycloaddition reactions. The reactions were carried out under solvent-free conditions and compared with the same reaction in the presence of a solvent and a catalyst. Steric effects on the selectivity of the reaction were noted and evaluated.

An enzyme and its optional [...] modified ketone and inhibitor composition comprising (by machine translation)

-

Paragraph 0392; 0393, (2017/01/23)

PROBLEM TO BE SOLVED: ketone-containing acrylic misuse, abuse or overload is prevented for a new takable amt. provitamin drag pain. SOLUTION: a compound represented by the following formula is represented, in which the drag oxystyrene provitamin hydrocodone ketone-containing acrylic. Pre-selected drug profile is modified and the ketone and schisandrin [...] holding hung contg. compsn. method for administration to a patient. Selected drawing: no (by machine translation)

Efficient synthesis of some new antiproliferative N-fused indoles and isoquinolines via 1,3-dipolar cycloaddition reaction in an ionic liquid

Sutariya, Tushar R.,Labana, Balvantsingh M.,Parmar, Narsidas J.,Kant, Rajni,Gupta, Vivek K.,Plata, Gabriela B.,Padrón, José M.

supporting information, p. 2657 - 2668 (2015/04/14)

Syntheses of some new pyrrolo-fused pyrrolo[1,2-a] indole derivatives have been achieved by combining N-allyl-indole-2-carbaldehyde with a variety of N-alkyl-glycine esters as well as tetrahydroisoquinolines in an ionic liquid, triethylammonium acetate (TEAA), a recyclable reaction medium, via intramolecular [3+2] cycloaddition reaction. This new method is highly efficient, and the ionic liquid employed is recyclable. The stereochemistry of all the compounds was confirmed by 2D NMR NOESY and in some cases single crystal X-ray diffraction data. The in vitro screening of all new candidates against various bacterial strains and representative human solid tumor cell lines, A549 (lung), HeLa (cervix), SW1573 (lung), T-47D (breast) and WiDr (colon), revealed that many of them have good antibacterial, antifungal and antitubercular and antiproliferative activities.

Selective monomethylation of primary amines with simple electrophiles

Lebleu, Thomas,Ma, Xiaolu,Maddaluno, Jacques,Legros, Julien

supporting information, p. 1836 - 1838 (2014/02/14)

Direct monomethylation of primary amines with methyl triflate was achieved with high selectivity (up to 96%). The key point of this single methyl transfer stems from the use of HFIP as the solvent that interferes with amines and avoids overmethylation.

A convenient 1,3-dipolar cycloaddition-reduction synthetic sequence from 2-allyloxy-5-nitro-salicylaldehyde to aminobenzopyran-annulated heterocycles

Parmar, Narsidas J.,Pansuriya, Bhavesh R.,Labana, Balvantsingh M.,Kant, Rajni,Gupta, Vivek K.

, p. 17527 - 17539 (2013/09/24)

A microwave-assisted, one-pot synthesis of some nitro benzopyran-annulated pyrroles as well as pyrrolo-fused isoquinolines via a 1,3-dipolar cycloaddition, which involves the in situ generation of azomethine ylide formed by reacting secondary amines with 2-allyloxy-5-nitro-salicylaldehyde, has been achieved in a solvent-free environment. Compared to methods of conventional and thermal heating, the present microwave-assisted method is rapid and highly efficient. In addition, amino analogous heterocycles were successfully accessed after treating the reaction mass further with iron in acidic medium, which also highlights a one-pot procedure for a new 1,3-dipolar cycloaddition-reduction synthetic sequence. All amino-products are new bioprofiles and anticipated to be effective drug-like candidates. All compounds were characterised based on their elemental analysis, mass, IR, and 1H and 13C NMR spectroscopic data. The stereochemistry of the product was confirmed by 2D NMR COSY and NOESY experiments, which, on the basis of single crystal X-ray diffraction data analysis, was further confirmed and supported.

An improved microwave assisted one-pot synthesis, and biological investigations of some novel aryldiazenyl chromeno fused pyrrolidines

Parmar, Narsidas J.,Pansuriya, Bhavesh R.,Barad, Hitesh A.,Kant, Rajni,Gupta, Vivek K.

supporting information; experimental part, p. 4075 - 4079 (2012/07/03)

An improved microwave assisted one-pot method for the synthesis of twelve new aryldiazenylchromeno [4,3-b] pyrrolidines via intramolecular azomethine ylide cycloaddition route is described. The method is efficient and advantageous over conventional and solvent-free thermal methods. The stereochemistry of the compounds was confirmed on the basis of various NMR experiments, and finally by single crystal X-ray diffraction data. N-Methyl or ethyl pyrrolidine based heterocycles gave good biological activities.

COMPOSITIONS COMPRISING ENZYME-CLEAVABLE PRODRUGS OF ACTIVE AGENTS AND INHIBITORS THEREOF

-

Page/Page column 309, (2011/11/06)

The present disclosure provides pharmaceutical compositions, and their methods of use, where the pharmaceutical compositions comprise a prodrug that provides enzymatically-controlled release of a drug and an enzyme inhibitor that interacts with the enzyme(s) that mediates the enzymatically-controlled release of the drug from the prodrug so as to attenuate enzymatic cleavage of the prodrug. The disclosure provides pharmaceutical compositions which comprise an enzyme inhibitor and a prodrug that contains an enzyme-cleavable moiety that, when cleaved, facilitates release of the drug.

Synthesis of novel diketopiperazine derivative and obsevation of self-assembled structure

Ohta, Yosuke,Terada, Kayo,Masuda, Toshio,Sanda, Fumio

experimental part, p. 2523 - 2530 (2010/04/25)

An N-monomethylated unsymmetrical diketopiperazine was synthesized from D-p-hydroxyphenylglycine and sarcosine, and condensed with trans-1,4-cyclohexanedicarboxylic acid to obtain the ester having diketopiperazine moieties at the both termini. Atomic force microscope measurement indicated that the ester formed a supramolecular structure aligned in a circular pattern based on hydrogen bonding between the amide groups of the diketopiperazine moieties.

Spiro-hydantoin compounds useful as anti-inflammatory agents

-

Page/Page column 39, (2008/06/13)

Compounds having the formula (I), and pharmaceutically-acceptable salts, hydrates, enantiomers, and diastereomers, and prodrugs thereof, are useful as inhibitors of LFA-1/ICAM and as anti-inflammatory agents, wherein L and K are O or S; Z is N or CR4b; Ar is an optionally-substituted aryl or heteroaryl; G is a linker attached to T or M or is absent; J, M and T are selected to define a three to six membered saturated or partially unsaturated non-aromatic ring; and R2 R4a, R4b, and R4c are as defined in the specification.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13200-60-7